Bryn Stole

Maryland will move into Phase 1B of its vaccination plan Monday. And the state would then open up the eligibility one week later, on Jan. 25, to Phase 1C.

The opening day of a Maryland General Assembly session typically has a feel of the first day of school. This year, the tone is more somber.

Dennis Schrader’s nomination as state health secretary is subject to a confirmation vote by the Maryland Senate, which he failed to win in 2017.

Without assurances from manufacturers and federal officials that they can ramp up production and delivery soon, Gov. Larry Hogan said, rushing out the state’s supply of second doses risks upending the vaccine rollout.

Gov. Larry Hogan says the Maryland Capitol Police are working with state and Annapolis-area law enforcement, "beefing up" plans for additional security at the State House, but that there have been no credible threats of violence.

Maryland Gov. Larry Hogan pledged Tuesday to make a renewed push for a more fair drawing of political districts in the state.

Democratic leaders in the state Senate unveiled a package of recommendations Monday aimed at addressing some racial disparities in environmental policy, health and access to government contracts, among other issues.

If approved by lawmakers and signed into law, the act would include initial payments to low- and moderate-income Marylanders, defined as those who have claimed the Earned Income Tax Credit

Leaders of the Democrat-dominated Maryland General Assembly say the pandemic offers a unique opportunity to address some long-standing problems that have become even more visible amid the health crisis.

Maryland Gov. Larry Hogan said he would be in favor of President Donald Trump resigning or being removed from office after a violent mob of his supporters stormed the U.S. Capitol Wednesday.

Hogan issued an executive order requiring all vaccine providers to report data on the state’s site, Immunet, within 24 hours. He also said that hospitals that haven’t used 75% of their vaccine allocations may get fewer doses in the future unless they can prove they can distribute efficiently.